|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
153,922,000 |
Market
Cap: |
6.15(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$39.95 - $39.95 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile IVERIC bio is biopharmaceutical company focused on the discovery and development of treatments for retinal diseases with unmet medical needs. Co.'s clinical stage product candidate, Zimura® (avacincaptad pegol), a complement C5 inhibitor. Co. is targeting the following diseases with Zimura: Geographic Atrophy, intermediate age-related macular degeneration, and autosomal recessive Stargardt disease. In addition to Zimura, Co. is developing its preclinical product candidate IC-500, a high temperature requirement A serine peptidase 1 protein inhibitor, for GA and potentially other age-related retinal diseases.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
541,223 |
Total Sell Value |
$0 |
$0 |
$0 |
$15,166,753 |
Total People Sold |
0 |
0 |
0 |
4 |
Total Sell Transactions |
0 |
0 |
0 |
28 |
End Date |
2024-06-27 |
2024-03-26 |
2023-09-26 |
2022-09-26 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Carroll David Francis |
SVP, CFO and Treasurer |
|
2022-01-03 |
4 |
S |
$16.39 |
$259,310 |
D/D |
(15,819) |
65,504 |
|
- |
|
Westby Keith |
SVP & COO |
|
2022-01-03 |
4 |
S |
$16.39 |
$201,265 |
D/D |
(12,278) |
128,280 |
|
- |
|
Carroll David Francis |
SVP, CFO and Treasurer |
|
2021-12-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
32,500 |
81,323 |
|
- |
|
Westby Keith |
SVP & COO |
|
2021-12-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
32,500 |
140,558 |
|
- |
|
Sblendorio Glenn |
CEO |
|
2021-12-31 |
4 |
AS |
$17.01 |
$13,621 |
D/D |
(801) |
279,133 |
|
- |
|
Sblendorio Glenn |
CEO |
|
2021-12-31 |
4 |
OE |
$2.94 |
$2,355 |
D/D |
801 |
279,934 |
|
- |
|
Sblendorio Glenn |
CEO |
|
2021-12-30 |
4 |
AS |
$17.01 |
$1,701 |
D/D |
(100) |
279,133 |
|
- |
|
Sblendorio Glenn |
CEO |
|
2021-12-30 |
4 |
OE |
$2.94 |
$294 |
D/D |
100 |
279,233 |
|
- |
|
Sblendorio Glenn |
CEO |
|
2021-12-27 |
4 |
AS |
$16.64 |
$86,990 |
D/D |
(5,229) |
279,133 |
|
- |
|
Sblendorio Glenn |
CEO |
|
2021-12-27 |
4 |
OE |
$1.45 |
$7,582 |
D/D |
5,229 |
284,362 |
|
- |
|
Sblendorio Glenn |
CEO |
|
2021-12-23 |
4 |
GD |
$0.00 |
$0 |
D/D |
60,000 |
279,133 |
|
- |
|
Sblendorio Glenn |
CEO |
|
2021-12-23 |
4 |
AS |
$16.96 |
$527,135 |
D/D |
(31,084) |
339,133 |
|
- |
|
Sblendorio Glenn |
CEO |
|
2021-12-23 |
4 |
OE |
$1.45 |
$57,701 |
D/D |
31,084 |
370,217 |
|
- |
|
Sblendorio Glenn |
CEO |
|
2021-12-22 |
4 |
AS |
$16.50 |
$365,783 |
D/D |
(22,163) |
339,133 |
|
- |
|
Sblendorio Glenn |
CEO |
|
2021-12-22 |
4 |
OE |
$1.45 |
$32,136 |
D/D |
22,163 |
361,296 |
|
- |
|
Westby Keith |
SVP & COO |
|
2021-12-21 |
4 |
AS |
$15.89 |
$317,744 |
D/D |
(20,000) |
108,058 |
|
- |
|
Carroll David Francis |
SVP, CFO and Treasurer |
|
2021-12-21 |
4 |
AS |
$15.98 |
$898,334 |
D/D |
(56,207) |
48,823 |
|
- |
|
Carroll David Francis |
SVP, CFO and Treasurer |
|
2021-12-20 |
4 |
S |
$15.44 |
$103,626 |
D/D |
(6,710) |
105,030 |
|
- |
|
Westby Keith |
SVP & COO |
|
2021-12-20 |
4 |
S |
$15.44 |
$69,743 |
D/D |
(4,516) |
128,058 |
|
- |
|
Sblendorio Glenn |
CEO |
|
2021-12-20 |
4 |
S |
$15.44 |
$286,075 |
D/D |
(18,524) |
339,133 |
|
- |
|
Carroll David Francis |
SVP, CFO and Treasurer |
|
2021-12-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,375 |
111,740 |
|
- |
|
Westby Keith |
SVP & COO |
|
2021-12-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,500 |
132,574 |
|
- |
|
Sblendorio Glenn |
CEO |
|
2021-12-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
36,658 |
357,657 |
|
- |
|
Dugel Pravin |
President |
|
2021-12-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,750 |
59,686 |
|
- |
|
Sblendorio Glenn |
Chief Executive Officer |
|
2021-12-13 |
4 |
S |
$14.74 |
$122,279 |
D/D |
(8,293) |
320,999 |
|
- |
|
459 Records found
|
|
Page 6 of 19 |
|
|